Progesterone inhibits apolipoprotein-mediated cellular lipid release: A putative mechanism for the decrease of high-density lipoprotein

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1532, Issue 3, 2001, Pages 173-184

  Kojima, Kazuhisa ^a   Abe Dohmae, Sumiko ^a   Arakawa, Reijiro ^a   Murakami, Isamu ^a   Suzumori, Kaoru ^a   Yokoyama, Shinji ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Apolipoprotein A I; Cholesterol; Estrogen; High density lipoprotein; Progesterone

Indexed keywords

APOLIPOPROTEIN A1; CAVEOLIN 1; CHOLESTEROL; CHOLESTEROL OXIDASE; CYCLODEXTRIN; ESTRADIOL; GESTAGEN; HIGH DENSITY LIPOPROTEIN; LIPID; MEDROXYPROGESTERONE ACETATE; MEVALONOLACTONE; NORETHISTERONE; NORGESTREL; PHOSPHOLIPID; PROGESTERONE;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIFFUSION; DRUG EFFECT; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS; CELL LINE; CHOLESTEROL; CORONARY ARTERIOSCLEROSIS; DOWN-REGULATION; ESTRADIOL; FIBROBLASTS; HORMONE REPLACEMENT THERAPY; HUMANS; LIPID METABOLISM; LIPOPROTEINS, HDL; PHOSPHOLIPIDS; PROGESTERONE; TRITIUM;

EID: 0035967791     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(01)00124-X     Document Type: Article

References (58)

1. High density lipoprotein - The clinical implications of recent studies
2. High density lipoproteins and coronary heart disease
3. Hydrolysis and excretion of cytoplasmic cholesterol esters by macrophages: Stimulation by high density lipoprotein and other agents
4. Cholesterol transport between cells and high density lipoproteins
5. Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women
6. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
7. Postmenopausal use of estrogen and occlusion of coronary arteries
8. The effects of postmenopausal estrogen therapy on the incidence of arteriosclerotic vascular disease
9. Association of exogenous estrogen and endometrial carcinoma
10. The menopause: Benefits and risks of estrogen-progestogen replacement therapy
11. Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women
12. Changes in the lipoprotein profile in postmenopausal women receiving hormone replacement therapy. Effects of natural and synthetic progesterone
13. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins
14. Lipoprotein and apoprotein levels in postmenopausal women during treatment with norethisterone
15. A dose-response relationship between sex hormone-induced change in hepatic triglyceride lipase and high-density lipoprotein cholesterol in postmenopausal women
16. Release of cellular cholesterol: Molecular mechanism for cholesterol homeostasis in cells and in the body
17. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease
18. Decreased reverse cholesterol transport from Tangier disease fibroblasts: Acceptor specificity and effect of brefeldin on lipid efflux
19. Selective inhibition of free apolipoprotein-mediated cellular lipid efflux by probucol
20. Apolipoprotein-mediated cellular cholesterol/phospholipid efflux and plasma high density lipoprotein level in mice
21. Mutations of ABC 1 in Tangier disease and familial high density lipoprotein deficiency
22. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
23. Tangier disease is caused by mutations in the gene encoding ATP-cassette transporter 1
24. Human ATP-binding cassette transporter 1 (ABC1): Genomic organization and identification of the genetic defect in the original Tangier disease kindred
25. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux
26. Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblasts monolayers
27. Involvement of caveolin-1 in cholesterol-enrichment of HDL during its assembly by apolipoprotein and THP-1 cells
28. Interaction of free apolipoproteins with macrophages: Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol
29. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids
30. Apolipoprotein-mediated cellular cholesterol efflux
31. The process of dissolving apolipoprotein A-I in an aqueous buffer
32. The role of vitamin D3 in the proliferation of a human colon cancer cell line in vitro
33. Phenol red in tissue culture media is weak estrogen: Implications concerning the study of estrogen-responsive cells in culture
34. Characterization of apolipoprotein-mediated HDL generation induced by cAMP in a murine macrophage cell line
35. Effects of sphingomyelin degradation on cell cholesterol oxidizability and steady-state distribution between the cell surface and the cell interior
36. Cloning of two novel ABC transporters mapping on human chromosome 9
37. Independent regulation of cholesterol incorporation into free apolipoprotein-mediated cellular lipid efflux in rat smooth muscle cells
38. Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cholesterol efflux in macrophages
39. Involvement of cellular surface factor(s) in lipid-free apolipoprotein-mediated cellular cholesterol efflux
40. Specific binding of apoA-I, enhanced cholesterol efflux and altered plasma membrane morphology in cells expressing ABC1
41. ABCA1 is the cAMP-induced apolipoprotein receptor that mediates cholesterol secretion from macrophages
42. Oxidative tyrosylation of HDL enhances the depletion of cellular cholesteryl esters by a mechanism independent of passive sterol desorption
43. High density lipoprotein apolipoproteins mediate removal of sterol from intracellular pools but not from plasma membranes of cholesterol-loaded fibroblasts
44. Efflux of intracellular versus plasma membrane cholesterol in HepG cells: Different availability and regulation by apolipoprotein A-I
45. Progesterone blocks cholesterol translocation from lysosomes
46. Intracellular cholesterol transport and compartmentation
47. Progesterone inhibits cholesterol biosynthesis in cultured cells. Accumulation of cholesterol precursors
48. High density lipoprotein stimulates sterol translocation between intracellular and plasma membrane pools in human monocyte-derived macrophages
49. HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients
50. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and abc1-deficient mice
51. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1
52. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway
53. Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation
54. A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane
55. Cholesterol-sphingomyelin interaction in membrane and apolipoprotein-mediated cellular cholesterol efflux
56. Progestin regulation of alkaline phosphatase in the human breast cancer cell line T47D
57. Plasma oestradiol and progesterone concentration in the normal menstrual cycle
58. Diurnal changes in the concentration of progesterone in the plasma of women at 34-35 weeks of gestation